Future studies using neurons derived from patients’ iPSCs are needed to determine the patient-specific mechanisms by which Kv1.2 variants lead to complex epileptic encephalopathy and ataxia [37,38]. This evidence concerns the gene KCNA2 and Epileptic encephalopathy.